跳至主要内容
临床试验/NCT03633994
NCT03633994Unknown2 期

Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy: A Randomized Controlled Trial

The Christ Hospital1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2018年8月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
104
试验地点
1
主要终点
Lower urinary tract symptoms

研究概览

简要总结

This study will explore the application of placing heparin into the bladder via a catheter to decrease postoperative lower urinary tract symptoms (LUTS) and urinary tract infection (UTI) symptoms such as urinary frequency, urinary urgency, pain with urination, or difficulty voiding following hysterectomy (surgically removing the uterus). The investigators hypothesize that heparin bladder instillations will reduce LUTS, UTI symptoms, and improve patient satisfaction following hysterectomy.

详细描述

Data Collection

Subject demographics and history information will be obtained from The Christ Hospital Medical Center's electronic medical record. In addition, preoperative diagnosis, postoperative diagnosis, procedure performed, total operative time, estimated blood loss, intraoperative complications, anterior prolapse repair, use of cystoscopy, preoperative urinalysis, postoperative complications, uterine size, and any urine cultures collected within the 2 week postoperative period will also obtained from the electronic medical record.

The post-operative lower urinary tract symptoms assessments will be collected, the paper records will be secured in a locker labeled with the study identification number, which will then be entered into EXCEL on a password secured database and the paper copy will be disposed of in the secure destruction station.

Descriptive Analysis

Simple statistics and demographics will be done across the two cohorts. Categorical variables will be analyzed using Chi-square while continuous variables (e.g. UTISA scores) will be analyzed using t-test so long as the distribution of the data are normal. Additional analyzes as appropriate will be done to identify group differences based on patient demographics (e.g. age, concomitant procedures, surgeon, estrogen use, foley catheter placement, etc).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 18 to 85-years old
  • scheduled to undergo a benign hysterectomy

排除标准

  • non-English speakers
  • current use of anticoagulants or thrombolytic agents
  • known adverse reaction or hypersensitivity to heparin
  • history of or active genitourinary tract cancer (bladder, uterine, cervical, ovarian or vaginal)
  • history of neurogenic bladder
  • pelvic irradiation
  • chemical cystitis
  • pregnancy
  • antibiotic use within the past 30 days
  • Surgical procedures involving: anterior or posterior colporrhaphy, vaginal mesh excision, fistula repair, diverticulum repair, urethral reconstruction, planned or incidental cystotomy

研究组 & 干预措施

Heparin Bladder Instillation

Experimental

At the completion of the scheduled benign hysterectomy, intravesicular bladder instillation containing 40,000U of heparin (40mL of 10,000U heparin/10mL) will be administered be introduced in a retrograde fashion by gravity via Foley catheter. The Foley catheter will be clamped for 30 minutes approximately 1cm from the vaginal opening.

干预措施: Heparin (Drug)

Normal Saline Bladder Instillation

Placebo Comparator

Patients randomized to the control group will undergo intravesical instillation with 40mL of normal saline. The Foley catheter will be clamped for 30 minutes approximately 1cm from the vaginal opening.

干预措施: Normal saline (Drug)

结局指标

主要结局

Lower urinary tract symptoms

时间窗: Postoperative day 14

lower urinary tract symptoms such as urgency, frequency, dysuria, and hematuria measured by the Urinary Tract Infection Symptoms Assessment Questionnaire (UTISA)

次要结局

  • Postoperative antibiotic use(Postoperative day 1 to 14)
  • Postoperative patient satisfaction(Postoperative day 14)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyde Yuen

Female Pelvic Medicine and Reconstructive Surgery Fellow

The Christ Hospital

研究点 (1)

Loading locations...

相似试验